Esperion Therapeutics | ESPR - Market Capitalization

Stock Price
3.49
Daily Change
0.10 2.80%
Monthly
-1.83%
Yearly
85.37%
Q1 Forecast
2.70

Esperion Therapeutics reported $620.9M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Amarin USD 341M 4M Sep/2025
Amgen USD 201.45B 25.2B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
CSL USD 76.3B 60.04B Jun/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Geron USD 874M 24M Sep/2025
Grifols EUR 6.77B 773M Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Heron Therapeutics USD 145M 6M Sep/2023
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Minerva Neurosciences USD 43M 5M Dec/2023
Moderna USD 10.09B 581M Sep/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vanda Pharmaceuticals USD 243M 136M Dec/2023